These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27521321)

  • 1. Acute Myeloid Leukemia: Past, Present, and Prospects for the Future.
    Short NJ; Ravandi F
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S25-9. PubMed ID: 27521321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute myeloid Leukemia].
    Braess J
    Dtsch Med Wochenschr; 2016 Nov; 141(24):1748-1751. PubMed ID: 27835920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
    Bose P; Vachhani P; Cortes JE
    Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment of acute myeloid leukemia.
    Roboz GJ
    Curr Opin Oncol; 2012 Nov; 24(6):711-9. PubMed ID: 23014187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfavorable-risk acute myeloid leukemia dissected.
    Strickland SA; Mohan SR; Savona MR
    Curr Opin Hematol; 2016 Mar; 23(2):144-9. PubMed ID: 26825699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blind men and the AML elephant: can we feel the progress?
    Tauro S
    Blood Cancer J; 2016 May; 6(5):e424. PubMed ID: 27176800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction therapy in acute myeloid leukemia: Is it time to put aside standard 3 + 7?
    Ferrara F; Vitagliano O
    Hematol Oncol; 2019 Dec; 37(5):558-563. PubMed ID: 30938858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia.
    Stone RM; O'Donnell MR; Sekeres MA
    Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future prospects of therapeutic clinical trials in acute myeloid leukemia.
    Khan M; Mansoor AE; Kadia TM
    Future Oncol; 2017 Mar; 13(6):523-535. PubMed ID: 27771959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia.
    Chen KTJ; Gilabert-Oriol R; Bally MB; Leung AWY
    Pharm Res; 2019 Jun; 36(9):125. PubMed ID: 31236772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Is the Optimal Induction Therapy for Younger Fit Patients With AML?
    Fernandez HF
    Curr Hematol Malig Rep; 2016 Oct; 11(5):327-32. PubMed ID: 27475430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontline treatment of acute myeloid leukemia in adults.
    Tamamyan G; Kadia T; Ravandi F; Borthakur G; Cortes J; Jabbour E; Daver N; Ohanian M; Kantarjian H; Konopleva M
    Crit Rev Oncol Hematol; 2017 Feb; 110():20-34. PubMed ID: 28109402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
    Reinhardt D; Langebrake C; Creutzig U; Vormoor J; Brune C; Thorwesten M; Ingiliz P; Hrusak O; Dworzak M; Griesinger F
    Klin Padiatr; 2002; 214(4):179-87. PubMed ID: 12165899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia.
    Rubnitz JE; Gibson B; Smith FO
    Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision therapy for acute myeloid leukemia.
    Yang X; Wang J
    J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New trends in the standard of care for initial therapy of acute myeloid leukemia.
    Fernandez HF
    Hematology Am Soc Hematol Educ Program; 2010; 2010():56-61. PubMed ID: 21239771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches to the treatment of acute myeloid leukemia.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2011; 2011():43-50. PubMed ID: 22160011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives.
    Guolo F; Minetto P; Clavio M; Miglino M; Lemoli RM; Gobbi M
    Biosci Trends; 2017 Mar; 11(1):110-114. PubMed ID: 28123146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.